Robert Matsuk, president of Glenmark North America, introduces the scope of the company’s operations in the US - including a manufacturing facility that obtained its first approval in 2019. Matsuk describes the unique business model a generic player in the US needs to maintain its competitiveness and conveys the role that the company plays in improving access to medicines.
From an overall manufacturing perspective, regardless of regional geography, it pays to diversify manufacturing activities
